Journal of Cancer Biology and Therapeutics

##issue.tableOfContents##

Research Article

Phase I/II Clinical Trial of Weekly Intraperitoneal Paclitaxel (IP-PTX) with Monthly Intravenous Carboplatin (IV-CBDCA) for Minimal Residual Disease of Ovarian, Tubal, and Peritoneal Carcinoma
Takeuchi S, Terai Y, Tanimura K, Miyamoto T, Omichi M, Takeuchi K
243-253
PDF
KRAS and NRAS Mutations in Moroccan Patients with Colorectal Cancer
Dehbi H, Ait boujmia OK, Benayad S, El Idrissi HH, Karkouri M
254-259
PDF
Postoperative Wound Complications in Fungating Extremity Soft Tissue Sarcomas
Blakely AM, Chow W, Sampath S, Femino JD, Lozano-Calderon S, Heng M, Crawford B
273-279
PDF
Immunohistochemical Determination of ATAD2 Protein Overexpression for Predicting Prognostic Value in Patients with Different Types of Cancer: A Meta-Analysis
Jiang S, Liu J, Chen X, Zheng X, Ruan J, Ye A, Zhang S, Zhang L, Kuang Z, Liu R
280-289
PDF

Review Article

Antimicrobial Peptides and Cancer: Potential Use of Antimicrobial-Like Peptides in Chemotherapy
Mizejewski GJ
233-242
PDF
Bone Complications in Allogenic Hematopoietic Stem Cell Transplantation
Saowapa S, Isenberg JS, Salehian B
260-272
PDF

Case Report

Multiple Myeloma and Primary Sjogren’s Syndrome Combined with Unexplained Elevation of CA-125 Levels
Jun Du, ShuHui Deng, LuGui Qiu, Gang An
211-216
PDF
Complete Response to Anti-PD-1 Antibody Monotherapy in Metastatic Melanoma-Can Therapy be Discontinued? A Review of Current Literature
Philip AZ
217-222
PDF
View All Issues